Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANTX compared with SABS: revenue, margins and what each company keeps, and the suppliers and customers both name
ANTX
AN2 Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
SABS
SAB Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANTX
AN2 Therapeutics, Inc.
vs
SABS
SAB Biotherapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ANTX, solid
SABS, dashed
ANTX
AN2 Therapeutics, Inc.
Change
4.00
▲
+1.14%
· post 4.00
Mkt cap
$150.9M
Revenue
—
SABS
SAB Biotherapeutics, Inc.
Change
3.02
▲
+2.59%
· post 3.02
Closed
Nov 6 '26
Mkt cap
$273.0M
Revenue
$114,698
Q4 FY24
vs
Compare
Closed
Nov 6 '26
ANTX
AN2 Therapeutics, Inc.
vs
SABS
SAB Biotherapeutics, Inc.
4.00
▲
+1.14%
post 4.00
Price
3.02
▲
+2.59%
post 3.02
$150.9M
Mkt cap
$273.0M
—
Revenue
$114,698
Q4 FY24
Change
Change
ANTX
4.00
▲
+1.14%
vs
SABS
3.02
▲
+2.59%
Closed
Nov 6 '26